health risks of glp 1 GLP-1 Drugs & What They Do Frontiers | Exploring the multifaceted

Thomas MK et al (2021) Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes

A.GongR.FriedrichV.EngelsbergerV.KretschmerL.WanischA.et al

Their studied mechanisms are complementary: one is examined for vascular and cytoprotective signaling and the other for cytoskeletal and migratory dynamics

81: 161168 [DOI] [PubMed] [Google Scholar] 174.Seino Y, Rasmussen MF, Nishida T, et al

A growing number of preclinical studies suggest that incretin receptor agonists may modulate core pathways involved in hepatic fibrogenesis, though whether these effects are direct or secondary to metabolic improvements remains an area of active investigation